Skip to content

How to administer TAKHZYRO?: A Comprehensive Patient Guide

4 min read

As the first preventive monoclonal antibody approved for hereditary angioedema (HAE), TAKHZYRO is a critical medication for managing the condition in patients as young as 2 years old. For many, this offers a life-changing alternative to older treatments with more complex administration schedules. This guide provides detailed instructions on how to administer TAKHZYRO correctly and safely, whether you are a patient or a caregiver.

Quick Summary

A detailed guide covering the essential steps for preparing and administering TAKHZYRO via subcutaneous injection. Includes selecting an injection site, technique, post-injection care, and important safety information for patients and caregivers.

Key Points

  • Prepare Your Supplies: Gather the prefilled syringe, alcohol swab, cotton ball, and sharps container before starting the injection process.

  • Warm to Room Temperature: Remove the syringe from the refrigerator 15 minutes before the injection, but do not use other methods to warm it.

  • Do Not Shake: Vigorous shaking of the prefilled syringe should be avoided to prevent damage to the medication.

  • Rotate Injection Sites: To help minimize irritation, use a different approved site (abdomen, thigh, or upper arm) for each injection.

  • Proper Technique is Key: Insert the needle at a 45- to 90-degree angle into a pinched skin fold, slowly push the plunger, and withdraw the needle carefully.

  • Dispose Safely: Immediately place the used syringe into an FDA-approved sharps container to prevent accidental needle sticks.

  • Know Allergic Reaction Symptoms: Be aware of signs of a serious allergic reaction, such as wheezing or hives, and seek immediate medical help if they appear.

In This Article

Understanding TAKHZYRO Administration

Before administering any medication, it is essential to consult with a healthcare professional. Information provided in this guide is for general knowledge and should not be taken as medical advice.

TAKHZYRO (lanadelumab-flyo) is a subcutaneous injection used to help prevent hereditary angioedema (HAE) attacks. It is provided as a ready-to-use solution in a prefilled syringe. The medication can be self-administered by patients aged 12 and older after they have received appropriate training from a healthcare professional. For children aged 2 to under 12, the injection must be administered by a trained caregiver or healthcare provider. Following the correct procedure is crucial for administering the medication as intended.

Preparing for Your TAKHZYRO Injection

Preparation is a vital first step. Always read the Instructions for Use provided with your medication. Here is a list of what you will need:

  • The TAKHZYRO prefilled syringe
  • An alcohol swab
  • A cotton ball or gauze pad
  • An adhesive bandage (optional)
  • An FDA-approved sharps disposal container

Before you begin, wash your hands thoroughly with soap and water. Retrieve the prefilled syringe from the refrigerator and allow it to sit at room temperature for at least 15 minutes before injecting. Do not warm the syringe using other methods, and do not shake it vigorously. Inspect the solution in the syringe before use. It should be clear to slightly yellow or opalescent. Do not use the syringe if the liquid is discolored, cloudy, or contains visible particles. If the syringe is cracked or damaged, do not use it and dispose of it properly.

Selecting and Preparing the Injection Site

Choosing the right location for the injection is important. The approved injection sites for TAKHZYRO are:

  • Abdomen (at least 2 inches away from the navel)
  • Thigh
  • Upper arm

To prepare the site, follow these steps:

  • Choose a different injection site for each injection. Do not inject into skin that is tender, bruised, scaly, or hard.
  • Clean the selected injection site with an alcohol swab and allow it to dry completely. Do not touch, fan, or blow on the cleaned area before injection.

The Subcutaneous Injection Process

Administering the injection involves a few simple, sequential steps. The majority of self-administrations take less than a minute.

  1. Remove the needle cap: Hold the syringe in one hand and carefully pull the needle cap straight off with the other hand. Avoid twisting. Never put the needle cap back on.
  2. Pinch the skin: With your free hand, gently pinch a 1-inch fold of skin at the cleaned injection site and hold it throughout the injection.
  3. Insert the needle: Using a quick, dart-like motion, insert the needle into the pinched skin at a 45- to 90-degree angle. Insert the needle all the way into the fatty layer of the skin.
  4. Inject the medication: Slowly push the plunger all the way down until it stops. This helps ensure the full dose is administered.
  5. Remove the needle: Once the plunger is fully depressed, slowly pull the needle straight out while maintaining the same angle.
  6. Release the skin: Gently release the pinched fold of skin.

After the Injection

Immediately following the injection, it is important to handle the injection site and the used syringe correctly.

  • Press a cotton ball or gauze pad over the injection site for about 10 seconds.
  • If needed, cover the site with an adhesive bandage.
  • Do not rub the injection site, as this can cause bruising or irritation.
  • Dispose of the used prefilled syringe immediately into an FDA-approved sharps disposal container. Never reuse the syringe.

TAKHZYRO Administration Comparison by Age Group

TAKHZYRO administration can differ based on the patient's age and who is administering the medication. The following table provides a comparison of these factors.

Feature Pediatric Patients (2 to <6 years old) Pediatric Patients (6 to <12 years old) Adult and Pediatric Patients (12+ years old)
Who Administers? Healthcare provider or caregiver Healthcare provider or caregiver Patient or caregiver (after training)
Supplies Needed Syringe, alcohol swab, bandage, sharps container Syringe, alcohol swab, bandage, sharps container Syringe, alcohol swab, bandage, sharps container

Important Safety Considerations

While TAKHZYRO is used for many, it is essential to be aware of potential serious side effects, including allergic reactions. Seek immediate medical attention if you or your child experience any of the following symptoms:

  • Wheezing or difficulty breathing
  • Chest tightness
  • Fast heartbeat
  • Faintness or dizziness
  • Rash or hives

Conclusion

Administering TAKHZYRO is a process that can be performed at home after proper training from a healthcare professional. By following the correct steps for preparation, injection, and post-injection care, patients and caregivers can help ensure the medication is delivered appropriately. Adherence to the prescribed dosing schedule is essential for the management of HAE attacks. Always consult your healthcare provider with any questions or concerns and be vigilant for signs of allergic reactions, seeking immediate medical care if they occur. Proper storage and disposal of the prefilled syringe are also critical components of the administration process.

For more information on TAKHZYRO, including safety and full prescribing information, visit the official Takeda product website at www.takhzyro.com.

Frequently Asked Questions

TAKHZYRO is a subcutaneous injection, and the recommended sites are the abdomen, thigh, or upper arm. It is important to rotate the injection site with each dose.

If you miss a dose of TAKHZYRO, contact your healthcare provider for guidance. Do not administer a double dose to make up for a missed one.

Store the TAKHZYRO prefilled syringe in the refrigerator between 36°F and 46°F (2°C and 8°C). Do not freeze it, and keep it in the original carton to protect from light.

Yes, it is normal to see air bubbles in the TAKHZYRO prefilled syringe. This will not affect your dose and is not a cause for concern.

Yes, patients 12 years of age and older can self-administer TAKHZYRO after receiving training from a healthcare provider. For children younger than 12, a caregiver or healthcare provider must administer the injection.

Injection site reactions like pain, redness, or bruising are common side effects. You can apply a cold compress to the area after injection. If the reaction is severe or persistent, contact your healthcare provider.

After use, the prefilled syringe must be placed immediately into an FDA-approved sharps disposal container. Follow your community guidelines for proper disposal of the full container.

Take the syringe out of the refrigerator 15 minutes prior to injection to reach room temperature. Do not shake it. Inspect the solution for discoloration or particles before use.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.